Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

United Therapeutics (UTHR) Interest & Investment Income (2017 - 2025)

Historic Interest & Investment Income for United Therapeutics (UTHR) over the last 15 years, with Q3 2025 value amounting to $46.4 million.

  • United Therapeutics' Interest & Investment Income fell 682.73% to $46.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.1 million, marking a year-over-year decrease of 134.46%. This contributed to the annual value of $199.1 million for FY2024, which is 2237.25% up from last year.
  • According to the latest figures from Q3 2025, United Therapeutics' Interest & Investment Income is $46.4 million, which was down 682.73% from $51.3 million recorded in Q2 2025.
  • In the past 5 years, United Therapeutics' Interest & Investment Income registered a high of $53.8 million during Q1 2024, and its lowest value of $3.8 million during Q3 2021.
  • Moreover, its 5-year median value for Interest & Investment Income was $37.2 million (2023), whereas its average is $30.1 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 5300.0% in 2021, then surged by 57906.98% in 2023.
  • Over the past 5 years, United Therapeutics' Interest & Investment Income (Quarter) stood at $4.2 million in 2021, then soared by 395.24% to $20.8 million in 2022, then soared by 145.19% to $51.0 million in 2023, then decreased by 3.33% to $49.3 million in 2024, then decreased by 5.88% to $46.4 million in 2025.
  • Its Interest & Investment Income stands at $46.4 million for Q3 2025, versus $51.3 million for Q2 2025 and $51.1 million for Q1 2025.